Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08HHT
|
|||
| Former ID |
DIB011518
|
|||
| Drug Name |
Procervix
|
|||
| Synonyms |
Cervical cancer vaccine, BT Pharma; CyaAE5-HPV16E7; HPV E7 cervical cancer vaccine (CyaA protein vector); HPV E7 cervical cancer vaccine (CyaA protein vector), Genticel
Click to Show/Hide
|
|||
| Indication | Human papillomavirus infection [ICD-11: 1A9Y; ICD-9: 078.1079.4] | Phase 2 | [1] | |
| Company |
Genticel
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01957878) Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.